Apyx Medical Company Insiders

APYX Stock  USD 4.40  0.38  9.45%   
Slightly above 66 percent of all Apyx Medical's insiders are acquiring. The analysis of insiders' sentiment of trading Apyx Medical stock suggests that a large number of insiders are confidant at this time. Apyx Medical employs about 220 people. The company is managed by 8 executives with a total tenure of roughly 29 years, averaging almost 3.0 years of service per executive, having 27.5 employees per reported executive.
Moshe Citronowicz  President
Senior Vice President
Todd Hornsby  President
Executive Vice President

Insider Sentiment 66

 Mostly Buying

 
Selling
 
Buying

Latest Trades

2024-08-13Matthew C HillAcquired 5336 @ 1.13View
2023-12-12Matthew C HillAcquired 2500 @ 2.19View
2023-06-26Todd HornsbyDisposed 15000 @ 7.56View
Monitoring Apyx Medical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median.
For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

Apyx Medical's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Apyx Medical's future performance. Based on our forecasts, it is anticipated that Apyx will maintain a workforce of slightly above 220 employees by March 2026.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Apyx Medical Management Team Effectiveness

The company has return on total asset (ROA) of (0.1006) % which means that it has lost $0.1006 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.6813) %, meaning that it created substantial loss on money invested by shareholders. Apyx Medical's management efficiency ratios could be used to measure how well Apyx Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.4 in 2026. Return On Capital Employed is likely to rise to -0.38 in 2026. At this time, Apyx Medical's Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 2 M in 2026, whereas Non Current Assets Total are likely to drop slightly above 8.3 M in 2026.
Common Stock Shares Outstanding is likely to drop to about 22.9 M in 2026. Net Loss is likely to rise to about (19.8 M) in 2026Apyx Medical holds a total of 41.03 Million outstanding shares. 30% of Apyx Medical outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2000-03-31
Previous Quarter
40.7 M
Current Value
40.7 M
Avarage Shares Outstanding
23.4 M
Quarterly Volatility
8.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Some institutional investors establish a significant position in stocks such as Apyx Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Apyx Medical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Apyx Medical Workforce Comparison

Apyx Medical is rated second in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 2,892. Apyx Medical holds roughly 220 in number of employees claiming about 8% of equities under Health Care industry.

Apyx Medical Profit Margins

The company has Profit Margin (PM) of (0.3) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.06) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.06.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.380.55
Way Down
Slightly volatile

Apyx Medical Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Apyx Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Apyx Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Apyx Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2026-03-01
1.0
1
1
 12,000 
 12,000 
2024-09-01
0.2857
2
7
 11,336 
 119,000 
2023-09-01
0.125
1
8
 5,338 
 131,000 
2023-06-01
0.6
3
5
 40,000 
 70,000 
2022-09-01
1.8889
17
9
 341,750 
 176,583 
2022-06-01
0.6667
2
3
 14,000 
 22,000 
2022-03-01
2.0
6
3
 535,173 
 41,173 
2021-03-01
3.0
6
2
 268,563 
 15,000 
2020-09-01
6.0
6
1
 102,000 
 17,000 
2019-12-01
0.5
1
2
 10,000 
 1,010,000 
2019-06-01
1.0
2
2
 8,000 
 8,000 
2019-03-01
1.5
6
4
 467,000 
 30,000 
2015-12-01
4.0
4
1
 120,000 
 35,000 
2015-09-01
2.5
5
2
 70,000 
 40,000 
2015-03-01
2.0
4
2
 12,818,139 
 426,000 
2014-09-01
8.0
8
1
 96,759 
 12,241 
2013-12-01
3.0
3
1
 45,000 
 4,000 
2012-09-01
9.0
9
1
 161,000 
 5,000 
2010-09-01
3.5
7
2
 65,000 
 10,750 
2010-03-01
0.5
1
2
 5,000 
 6,000 
2009-12-01
0.8571
6
7
 57,500 
 5,000 
2008-12-01
0.3478
8
23
 760,000 
 830,546 
2008-09-01
1.5
3
2
 35,000 
 40,000 
2008-06-01
0.6667
2
3
 50,000 
 51,500 
2008-03-01
0.5556
5
9
 477,000 
 550,664 
2007-12-01
1.0
1
1
 7,500 
 1,500 
2007-06-01
0.5
1
2
 3,000 
 15,000 
2007-03-01
0.6364
7
11
 92,500 
 137,000 
2006-12-01
1.0
3
3
 115,000 
 115,000 
2006-03-01
1.1
11
10
 235,000 
 140,000 
2005-12-01
1.25
5
4
 55,000 
 60,000 
2005-06-01
5.75
23
4
 615,000 
 10,000 
2005-03-01
1.0
1
1
 20,000 
 10,000 
2004-09-01
3.6
18
5
 450,000 
 3,085,000 
2003-09-01
7.0
7
1
 185,000 
 10,000 

Apyx Medical Notable Stakeholders

An Apyx Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Apyx Medical often face trade-offs trying to please all of them. Apyx Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Apyx Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Charles IICEO PresidentProfile
Stavros BComExecutive ChairmanProfile
Moshe CitronowiczSenior Vice PresidentProfile
Todd HornsbyExecutive Vice PresidentProfile
Tara SembTreasurer CFOProfile
Dolores CataniaChief ConfidenceProfile
Shawn RomanChief OfficerProfile
Matthew CPAChief OfficerProfile
String symbol = request.getParameter("s");

About Apyx Medical Management Performance

The success or failure of an entity such as Apyx Medical often depends on how effective the management is. Apyx Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Apyx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Apyx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.42)(0.40)
Return On Capital Employed(0.40)(0.38)
Return On Assets(0.42)(0.40)
Return On Equity(1.90)(1.80)
Please note, the imprecision that can be found in Apyx Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Apyx Medical. Check Apyx Medical's Beneish M Score to see the likelihood of Apyx Medical's management manipulating its earnings.

Apyx Medical Workforce Analysis

Traditionally, organizations such as Apyx Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Apyx Medical within its industry.

Apyx Medical Manpower Efficiency

Return on Apyx Medical Manpower

Revenue Per Employee218.6K
Revenue Per Executive6M
Net Loss Per Employee107.1K
Net Loss Per Executive2.9M
Working Capital Per Employee207.8K
Working Capital Per Executive5.7M

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.